Home › Funds › Kiltearn Partners LLP › SOLV
Kiltearn Partners LLP position in SOLV
SOLVENTUM CORP · Health Care
Kiltearn Partners LLP reported holding 93,210 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$8.2M, representing 1.98% of its reported portfolio and ranking #19 among its reported holdings. Kiltearn Partners LLP has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Kiltearn Partners LLP's SOLV position evolved
Kiltearn Partners LLP first disclosed a stake in SOLV in Q3 2024 at 40,700 shares (US$2.8M). The position peaked in Q3 2026 at 93,210 shares, worth US$8.2M. Across 9 filings, Kiltearn Partners LLP increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 93,210 shares valued at US$8.2M — a reduction of -4,193 shares quarter over quarter.. Notable position changes include a 81% increase in Q4 2024 (shares rose 15% over the following quarter), a 37% increase in Q1 2025 (shares were roughly flat over the following quarter), a 30% increase in Q1 2026 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 40.70K | $2.84M | New |
| Q4 2024 | 73.50K | $4.86M | Add |
| Q1 2025 | 100.60K | $7.65M | Add |
| Q2 2025 | 99.50K | $7.55M | Reduce |
| Q3 2025 | 93.00K | $6.79M | Reduce |
| Q4 2025 | 78.91K | $6.25M | Reduce |
| Q1 2026 | 102.30K | $6.68M | Add |
| Q2 2026 | 97.40K | $7.51M | Reduce |
| Q3 2026 | 93.21K | $8.22M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SOLV and 13F data
SOLV (SOLVENTUM CORP) is a Health Care company. 41 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SOLV
- Independent Franchise Partners LLP 15.67M sh · $1.38B · Q3 2026
- TRIAN FUND MANAGEMENT, L.P. 8.24M sh · $635.47M · Q2 2026
- DAVIS SELECTED ADVISERS 6.41M sh · $565.42M · Q3 2026
- Diamond Hill Capital Management, LLC (Investment Advisor) 1.58M sh · $139.38M · Q3 2026
- Madison Avenue Partners, LP 1.74M sh · $134.34M · Q2 2026
- EQUITY INVESTMENT CORP 867.55K sh · $76.47M · Q3 2026
- ANCHOR CAPITAL ADVISORS LLC 533.38K sh · $47.02M · Q3 2026
More on Kiltearn Partners LLP
FAQ
How long has Kiltearn Partners LLP held SOLV?
Kiltearn Partners LLP has disclosed SOLV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Kiltearn Partners LLP's current position in SOLV?
As of Q3 2026, Kiltearn Partners LLP holds 93.21K shares of SOLV (SOLVENTUM CORP), valued at $8.22M, representing 1.98% of its reported portfolio and ranking #19.
Has Kiltearn Partners LLP been buying or selling SOLV?
In the latest 13F filing (Q3 2026), Kiltearn Partners LLP reduced its position in SOLV. The position peaked in Q3 2026 at 93.21K shares.
Which other funds hold SOLV?
Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.